Anatomically compartmentalized human immunodeficiency virus replication in HLA-DR+ cells and CD14+ macrophages at the site of pleural tuberculosis coinfection

Journal of Infectious Diseases

Volumn 184, Issue 9, 2001, Pages 1127-1133

  Lawn, S D ^a   Pisell, T L ^a   Hirsch, C S ^b   Wu, M ^b   Butera, S T ^a   Toossi, Z ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD19 ANTIGEN; CD36 ANTIGEN; DIPEPTIDYL PEPTIDASE IV; HERMES ANTIGEN; HLA DR ANTIGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; OPPORTUNISTIC INFECTION; PHENOTYPE; PLEURA DISEASE; PRIORITY JOURNAL; TUBERCULOUS PLEURISY; VIRUS REPLICATION;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIGENS, CD14; ANTIGENS, CD26; CELL COMPARTMENTATION; HIV-1; HLA-DR ANTIGENS; HUMANS; MACROPHAGES; PLEURAL EFFUSION; T-LYMPHOCYTES; TUBERCULOSIS, PLEURAL; VIRUS REPLICATION;

EID: 0035500970     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/323649     Document Type: Article

References (57)

1. Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type I infection
2. Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation
3. The effect of acute infectious illnesses on plasma human immunodeficiency virus type 1 load and the expression of serologic markers of immune activation among HIV-infected adults
4. The impact of active herpes simplex virus infection on human immunodeficiency virus load
5. A study of HIV RNA viral load in AIDS patients with bacterial pneumonia
6. Increased in vitro tetanus-induced production of HIV type 1 following in vivo immunization of HIV type 1-infected individuals with tetanus toxoid
7. Greater diversity of HIV-1 quasispecies in HIV-infected individuals with active tuberculosis
8. Immune activation is a dominant factor in the pathogenesis of African AIDS
9. Accelerated course of HIV infection after tuberculosis
10. Viral load and heterosexual transmission of human immunodeficiency virus type 1
11. Generalised immune activation in pulmonary tuberculosis: Coactivation with HIV infection
12. Tuberculosis and HIV infection are independently associated with elevated serum concentrations of tumour necrosis factor receptor type 1 and beta2-microglobulin, respectively
13. Sustained plasma TNF-α and HIV-1 load despite resolution of other immune activation parameters during treatment for tuberculosis in Africans
14. High human immunodeficiency virus type 1 RNA load in the cerebrospinal fluid from patients with lymphocytic meningitis
15. Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung
16. Correlation between HIV-1 RNA levels in the female genital tract and immune activation resulting from ulceration of the cervix
17. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1
18. Macrophages as a source of HIV during opportunistic infections
19. HIV and T cell expansion in splenic white pulps is accompanied by infiltration of HIV-specific cytotoxic T lymphocytes
20. T helper cell activation and human retroviral pathogenesis
21. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
22. Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1)
23. Enhanced susceptibility of blood monocytes from patients with pulmonary tuberculosis to productive infection with human immunodeficiency virus type 1
24. Phagocytosis of Mycobacterium tuberculosis modulates human immunodeficiency virus replication in human monocytic cells
25. Mycobacterium tuberculosis and its purified protein derivative activate expression of human immunodeficiency virus
26. Mycobacterium tuberculosis enhances HIV-1 replication by transcriptional activation at the long terminal repeat
27. Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expression
28. CD14 is involved in control of human immunodeficiency virus type 1 expression in latently infected cells by lipopolysaccharide
29. Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro
30. Activation of human monocyte-derived macrophages with lipopolysaccharide decreases human immunodeficiency virus replication in vitro at the level of gene expression
31. Differentiation of monocytes to macrophages switches the Mycobacterium tuberculosis effect on HIV-1 replication from stimulation to inhibition: Modulation of interferon response and CCAAT/enhancer binding protein beta expression
32. HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time
33. Coinfection with opportunistic pathogens promotes human immunodeficiency virus type 1 infection in macrophages
34. CD4 T cells remain the major source of HIV-1 during end stage disease
35. The acquisition of host-encoded proteins by nascem HIV-I
36. Cellular compartments of HIV-1 replication: Determination by virion-associated host proteins and the impact of opportunistic infection in vivo
37. Augmentation of apoptosis and interferon-gamma production at sites of active Mycobacterium tuberculosis infection in human tuberculosis
38. Incorporation of HLA-DR into the HIV-1 envelope: Correlation with stage of disease and the effect of opportunistic infection in vivo
39. HIV type 1 grown on interferon-γ - Treated U937 cells shows selective increase in virion-associated intercellular adhesion molecule 1 and HLA-DR and enhanced infectivity for CD4-negative cells
40. The interferons. Mechanisms of action and clinical applications
41. Soluble interleukin-2-receptors are released from activated human lymphoid cells in vitro
42. CD14: Cell surface receptor and differentiation marker
43. Elevated serum concentrations of soluble CD14 in HIV-negative and HIV-positive patients with tuberculosis in Africa: Prolonged elevation during antituberculosis treatment
44. + T cells
45. The acquisition of host-derived major histocompatibility complex class II glycoproteins by human immunodeficiency virus type 1 accelerates the process of virus entry and infection in human T-lymphoid cells
46. The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity
47. Partial activation and induction of apoptosis in CD4(+) and CD8(+) T lymphocytes by conformationally authentic noninfectious human immunodeficiency virus type 1
48. Defective antigen presentation by Mycobacterium tuberculosis-infected monocytes
49. Attenuation of HLA-DR expression by mononuclear phagocytes infected with Mycobacterium tuberculosis is related to intracellular sequestration of immature class II heterodimers
50. Differential tolerance induction by lipoarabinomannan and lipopolysaccharide in human macrophages
51. Involvement of CD14 in lipopolysaccharide-induced tumour necrosis factor-α, IL-6 and IL-8 release by human monocytes and alveolar macrophages
52. Detection of lipoarabinomannan as a diagnostic test for tuberculosis
53. Regulated expression of CD36 during monocyte-to-macrophage differentiation: Potential role of CD36 in foam cell formation
54. Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators
55. Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone
56. Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms
57. Regulation of MHC class II genes: Lessons from a disease